A Multicenter Feasibility Study With S-1, Oxaliplatin and Oral Leucovorin (SOL) for the Patients With Untreated Metastatic Colorectal Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 18 May 2015
At a glance
- Drugs Folinic acid (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 03 May 2010 New trial record